Literature DB >> 11021845

The risk of bias from omitted research.

S Garattini, A Liberati.   

Abstract

Mesh：

Year:  2000        PMID： 11021845      PMCID： PMC1118663          DOI： 10.1136/bmj.321.7265.845

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  9 in total

1.  Large-scale hormone replacement therapy and life expectancy: results from an international comparison among European and North American populations.

Authors:  S Panico; R Galasso; E Celentano; A V Ciardullo; L Frova; R Capocaccia; M Trevisan; F Berrino
Journal:  Am J Public Health       Date:  2000-09       Impact factor: 9.308

2.  Systematic reviews of trials and other studies.

Authors:  A J Sutton; K R Abrams; D R Jones; T A Sheldon; F Song
Journal:  Health Technol Assess       Date:  1998       Impact factor: 4.014

3.  Getting to grips with Archie Cochrane's agenda.

Authors:  I Chalmers; K Dickersin; T C Chalmers
Journal:  BMJ       Date:  1992-10-03

4.  Exclusion of the elderly and women from coronary trials. Is their quality of care compromised?

Authors:  N K Wenger
Journal:  JAMA       Date:  1992-09-16       Impact factor: 56.272

5.  Factors influencing publication of research results. Follow-up of applications submitted to two institutional review boards.

Authors:  K Dickersin; Y I Min; C L Meinert
Journal:  JAMA       Date:  1992-01-15       Impact factor: 56.272

Review 6.  Choosing between randomised and non-randomised studies: a systematic review.

Authors:  A Britton; M McKee; N Black; K McPherson; C Sanderson; C Bain
Journal:  Health Technol Assess       Date:  1998       Impact factor: 4.014

7.  Quality, evolution, and clinical implications of randomized, controlled trials on the treatment of lung cancer. A lost opportunity for meta-analysis.

Authors:  A Nicolucci; R Grilli; A A Alexanian; G Apolone; V Torri; A Liberati
Journal:  JAMA       Date:  1989-10-20       Impact factor: 56.272

8.  The impact of clinical trials on the use of medications for acute myocardial infarction. Results of a community-based study.

Authors:  N F Col; T J McLaughlin; S B Soumerai; D W Hosmer; J Yarzebski; J H Gurwitz; J M Gore; R J Goldberg
Journal:  Arch Intern Med       Date:  1996-01-08

Review 9.  Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women.

Authors:  R Fossati; C Confalonieri; V Torri; E Ghislandi; A Penna; V Pistotti; A Tinazzi; A Liberati
Journal:  J Clin Oncol       Date:  1998-10       Impact factor: 44.544
  9 in total
  3 in total

1.  Drug development means economics in the end.

Authors:  S Senn
Journal:  BMJ       Date:  2001-03-17

2.  Treating the patient or the population? Part 2. Judging the benefit of a treatment to society as a whole.

Authors:  T D Heller; R F Heller; S Pattison; R Fletcher
Journal:  West J Med       Date:  2001-08

Review 3.  All great truths are iconoclastic: selective decontamination of the digestive tract moves from heresy to level 1 truth.

Authors:  Hendrick K F van Saene; Andy J Petros; Graham Ramsay; Derrick Baxby
Journal:  Intensive Care Med       Date:  2003-04-10       Impact factor: 17.440
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.